Renaissance Technologies LLC purchased a new stake in Modular Medical, Inc. (NASDAQ:MODD – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 24,800 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.06% of Modular Medical at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in Modular Medical by 45.0% in the third quarter. Geode Capital Management LLC now owns 306,440 shares of the company’s stock valued at $690,000 after acquiring an additional 95,072 shares during the period. Virtu Financial LLC acquired a new stake in Modular Medical during the third quarter valued at approximately $44,000. Navigation Wealth Management Inc. grew its stake in shares of Modular Medical by 233.8% in the 4th quarter. Navigation Wealth Management Inc. now owns 61,040 shares of the company’s stock valued at $84,000 after purchasing an additional 42,754 shares during the period. Finally, Bard Associates Inc. raised its holdings in shares of Modular Medical by 47.1% in the 4th quarter. Bard Associates Inc. now owns 2,152,464 shares of the company’s stock worth $2,949,000 after buying an additional 689,534 shares in the last quarter. Institutional investors and hedge funds own 27.47% of the company’s stock.
Insiders Place Their Bets
In related news, CEO Manchester Management Co Llc purchased 156,250 shares of Modular Medical stock in a transaction that occurred on Thursday, March 20th. The shares were acquired at an average price of $1.92 per share, for a total transaction of $300,000.00. Following the transaction, the chief executive officer now directly owns 422,000 shares in the company, valued at approximately $810,240. This represents a 58.80 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 20.46% of the company’s stock.
Modular Medical Price Performance
Modular Medical (NASDAQ:MODD – Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.01).
Modular Medical Profile
Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
Featured Stories
- Five stocks we like better than Modular Medical
- What Are Dividend Champions? How to Invest in the Champions
- IBM’s AI Offensive: Assessing IBM’s Path to Renewed Growth
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Rockwell Automation: Tailwinds From Onshoring U.S. Production
- How Investors Can Find the Best Cheap Dividend Stocks
- Is Energy Transfer Undervalued or a Value Trap?
Want to see what other hedge funds are holding MODD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Modular Medical, Inc. (NASDAQ:MODD – Free Report).
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.